Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $30 Million - $33.3 Million
-143,300 Reduced 28.95%
351,724 $76.8 Million
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $72.4 Million - $83.3 Million
366,335 Added 284.67%
495,024 $113 Million
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $15.9 Million - $17.5 Million
79,116 Added 159.59%
128,689 $25.9 Million
Q2 2023

Aug 14, 2023

SELL
$211.93 - $241.33 $69.1 Million - $78.6 Million
-325,873 Reduced 86.8%
49,573 $12 Million
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $51.9 Million - $62.7 Million
243,278 Added 184.07%
375,446 $86.1 Million
Q4 2022

Feb 14, 2023

SELL
$203.72 - $248.97 $9.12 Million - $11.1 Million
-44,749 Reduced 25.29%
132,168 $31.1 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $67.9 Million - $87 Million
-331,664 Reduced 65.21%
176,917 $36.2 Million
Q2 2022

Aug 15, 2022

BUY
$213.86 - $277.87 $42.3 Million - $54.9 Million
197,612 Added 63.55%
508,581 $119 Million
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $64.4 Million - $73.9 Million
-247,985 Reduced 44.37%
310,969 $82 Million
Q4 2021

Feb 14, 2022

SELL
$271.6 - $314.21 $18.9 Million - $21.8 Million
-69,525 Reduced 11.06%
558,954 $176 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $29 Million - $32.5 Million
105,499 Added 20.17%
628,479 $177 Million
Q2 2021

Aug 16, 2021

SELL
$251.87 - $278.14 $35.1 Million - $38.8 Million
-139,342 Reduced 21.04%
522,980 $144 Million
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $91.1 Million - $113 Million
444,502 Added 204.07%
662,322 $169 Million
Q4 2020

Feb 16, 2021

SELL
$186.91 - $214.42 $64 Million - $73.5 Million
-342,661 Reduced 61.14%
217,820 $44.3 Million
Q3 2020

Nov 16, 2020

SELL
$167.03 - $201.3 $68.6 Million - $82.7 Million
-410,870 Reduced 42.3%
560,481 $106 Million
Q2 2020

Aug 14, 2020

BUY
$113.31 - $182.44 $99.9 Million - $161 Million
881,644 Added 982.8%
971,351 $161 Million
Q1 2020

May 15, 2020

BUY
$104.32 - $195.28 $3.26 Million - $6.11 Million
31,289 Added 53.56%
89,707 $11.3 Million
Q4 2019

Feb 14, 2020

SELL
$163.48 - $173.61 $76.1 Million - $80.8 Million
-465,649 Reduced 88.85%
58,418 $9.88 Million
Q3 2019

Nov 14, 2019

SELL
$159.77 - $178.1 $54.2 Million - $60.4 Million
-338,985 Reduced 39.28%
524,067 $88 Million
Q2 2019

Aug 14, 2019

BUY
$144.16 - $172.9 $16.4 Million - $19.7 Million
114,014 Added 15.22%
863,052 $149 Million
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $46 Million - $58.1 Million
371,630 Added 98.47%
749,038 $0
Q4 2018

Feb 14, 2019

BUY
$120.82 - $174.09 $21.9 Million - $31.5 Million
181,227 Added 92.38%
377,408 $47.7 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $32.3 Million - $36.3 Million
192,860 Added 5807.29%
196,181 $0
Q2 2018

Aug 10, 2018

SELL
$160.33 - $189.41 $18.5 Million - $21.9 Million
-115,528 Reduced 97.21%
3,321 $0
Q1 2018

May 11, 2018

SELL
$161.53 - $178.11 $3.22 Million - $3.55 Million
-19,952 Reduced 14.37%
118,849 $19.2 Million
Q4 2017

Feb 09, 2018

SELL
$147.99 - $163.95 $41 Million - $45.4 Million
-276,929 Reduced 66.61%
138,801 $22.1 Million
Q3 2017

Nov 09, 2017

BUY
$149.47 - $160.56 $62.1 Million - $66.7 Million
415,730
415,730 $62.8 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.